(Q47340953)

English

DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. (English)

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

DNA methylation

0 references

0 references

Sabine Zöchbauer-Müller

8

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

author name string

Sonja Seidl

1

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Jutta Ackermann

2

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Hannes Kaufmann

3

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Andrea Keck

4

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Thomas Nösslinger

5

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Christoph C Zielinski

6

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

Johannes Drach

7

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

100

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

2598-2606

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

12

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

The biology of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

New insights into the pathophysiology of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Methylation profiling in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Methylation of the p16INK4A gene in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Cadherins and the tumour progression: is it all in a switch?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

21 January 2018

Multiple myeloma: almost all patients are cytogenetically abnormal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

7 January 2021

based on heuristic

inferred from DOI database lookup

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20295

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20295

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/15197802

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47340953&oldid=1424642709"